Acetic acid in aged vinegar affects molecular targets for thrombus disease management

2015 ◽  
Vol 6 (8) ◽  
pp. 2845-2853 ◽  
Author(s):  
Li Jing ◽  
Zhang Yanyan ◽  
Fan Junfeng

To elucidate the mechanism underlying the action of dietary vinegar on antithrombotic activity, acetic acid, the main acidic component of dietary vinegar, was used to determine antiplatelet and fibrinolytic activity.

BioResources ◽  
2021 ◽  
Vol 16 (4) ◽  
pp. 6831-6849
Author(s):  
Suling Liu ◽  
Chenghsin Hu ◽  
Kuntsung Lu

Crude vinegar was prepared from Mikania micrantha plants using a steel kiln. The ether-extracted vinegar and acidic, phenolic, and neutral fractions were obtained by the partition method. The fundamental properties of crude vinegar, including its fractions applied to repel biting midges (Forcipomyia taiwana), were investigated. Results indicated that the crude vinegar had a moisture content of 91%, Gardner color value of 11.2, a reddish-brown color, specific gravity of 1.0164, pH of 5.36, organic acid content of 2.50%, and soluble tar content of 0.78%. In ether-extracted vinegar of M. micrantha, the acidic component was the major ingredient, followed by the neutral, phenolic, and nitrogenous components. The main organic compounds of the acidic, phenolic, nitrogenous, and neutral components were acetic acid, phenol, 3-pyridinol, and 2-furanmethanol, respectively. The results also demonstrated that the crude vinegar, ether-extracted vinegar, and the phenolic and neutral fractions effectively repelled biting midges, with absolute repellent times of 49, 87, 83, and 99 min, respectively. The repellent activity of ether-extracted vinegar and the phenolic and neutral fractions of M. micrantha vinegar on biting midges was higher than that of a commercial repellent agent (named Dinling) with absolute repellent time of 61 min.


2008 ◽  
Vol 36 (04) ◽  
pp. 719-727 ◽  
Author(s):  
Yan-Hong Li ◽  
Xiao-Ping Sun ◽  
Yin-Qing Zhang ◽  
Ning-Sheng Wang

Borneol is consumed excessively in China and Southeast Asian countries particularly in combined formula for preventing cardiovascular disease, but few studies were conducted on its effects on thrombosis. In this study, the antithrombotic and antiplatelet activities of borneol were investigated on thrombosis in vivo and on platelet aggregation ex-vivo. In addition, the coagulation parameters and influence on fibrinolytic activity were also assessed. The results showed that borneol had concentration dependent inhibitory effects on arterio-venous shunt and venous thrombosis but no effect on ADP and AA-induced platelet aggregation. Meanwhile, borneol prolonged the coagulation parameters for prothrombin time (PT) and thrombin time (TT), but did not show any fibrinolytic activity. It suggested that the antithrombotic activity of borneol and its action in combined formula for preventing cardiovascular diseases might be due to anticoagulant activity rather than antiplatelet activity.


1959 ◽  
Vol 196 (4) ◽  
pp. 775-778 ◽  
Author(s):  
Zbigniew Latallo ◽  
Stefan Niewiarowski ◽  
Alfred L. Copley

Comparative studies on 10 mammals showed that, in contrast to all the others, guinea pig serum alone, on precipitation with acetic acid, pH 5.3–5.4 at 4°C, yielded a euglobulin with high spontaneous fibrinolytic activity. Fibrinolytic and proteolytic activities of guinea pig, bovine and human euglobulins after addition of streptokinase (SK), SK-human plasminogen mixture, and without any activators were compared; antiplasmin activity was also investigated. When guinea pig serum was substituted for human serum in a mixture of the latter with SK, there was no activation of bovine plasminogen. A plasmin-antiplasmin complex may be the chief component of the guinea pig serum fibrinolytic system.


2007 ◽  
Vol 98 (12) ◽  
pp. 1208-1214 ◽  
Author(s):  
Maria Rossiello ◽  
Tiziana Ammollo ◽  
Fabrizio Semeraro ◽  
Donatella Piro ◽  
Mario Colucci

SummaryAnticoagulants have been shown to stimulate fibrinolysis principally via inhibition of thrombin-mediated activation of TAFI (thrombin activatable fibrinolysis inhibitor). Their profibrinolytic effect,however,may vary according to their mechanism of action and to the clot composition. We compared the fibrinolytic activity of the direct thrombin inhibitor melagatran with that of unfractionated heparin in platelet-poor (PPP) and platelet-rich (PRP) models consisting of tissue-factor-induced clots exposed to exogenous t-PA (25 ng/ml). In the PPP clot model, both heparin (0.1–0.6 U/ml) and melagatran (20–320 ng/ml) caused a concentration- dependent shortening of lysis time. However, when drug profibrinolytic activity (lysis ratio) was expressed in function of the aPTT prolongation (aPTT ratio), melagatran was more efficient than heparin. In the PRP clot model, melagatran displayed a fibrinolytic activity fairly comparable to that observed in PPP whilst heparin caused a modest reduction of lysis time only at the highest concentrations. Assay of thrombin and TAFIa generation in defibrinated plasma showed that the presence of platelets markedly reduced the ability of heparin,but not that of melagatran, to inhibit the formation of these enzymes. Altogether these data indicate that melagatran is more efficient than heparin in promoting fibrinolysis, particularly in plateletrich clots, and may thus grant a greater antithrombotic activity by enhancing thrombus dissolution.


2007 ◽  
Vol 97 (01) ◽  
pp. 27-31 ◽  
Author(s):  
Rémi Varin ◽  
Shahsultan Mirshahi ◽  
Pezhman Mirshahi ◽  
Gerald Kierzek ◽  
David Sebaoun ◽  
...  

SummaryFondaparinux is a synthetic pentasaccharide consisting of the minimal sequence of heparin which interacts with antithrombin (AT). It represents a new class of selective factor Xa inhibitors without any antithrombin activity. It has been shown to exhibit potent antithrombotic properties in clinical studies. However, the mechanism of its antithrombotic action has not yet been fully established. In the present study it was shown that fondaparinux, used at pharmacological concentration (500 ng/ml), rendered the clot more susceptible to fibrinolysis induced by t-PA: plasma fibrin clots formed in the presence of fondaparinux and perfused with t-PA were degraded at a faster rate than those formed in the absence of fondaparinux. This fibrinolytic activity of fondaparinux is mainly due to a modification of clot structure characterized by a loose fibrin conformation with less branched fibers and the presence of large pores in comparison to control clots which present a tighter conformation. The difference in fibrin structure was responsible for an increase in clot porosity leading to a better availability of t-PA to the fibrin network. It is related to the decrease in thrombin generation, in an AT-dependent pathway. It was also demonstrated that in the presence of exogenous thrombomodulin, the inhibition of TAFI activation by fondaparinux could contribute, to a lesser extent, to the increased thrombus lysis. The increase in t-PA induced thrombus lysis could contribute to the antithrombotic activity of fondaparinux.


Author(s):  
N.C. Lyon ◽  
W. C. Mueller

Schumacher and Halbsguth first demonstrated ectodesmata as pores or channels in the epidermal cell walls in haustoria of Cuscuta odorata L. by light microscopy in tissues fixed in a sublimate fixative (30% ethyl alcohol, 30 ml:glacial acetic acid, 10 ml: 65% nitric acid, 1 ml: 40% formaldehyde, 5 ml: oxalic acid, 2 g: mecuric chloride to saturation 2-3 g). Other workers have published electron micrographs of structures transversing the outer epidermal cell in thin sections of plant leaves that have been interpreted as ectodesmata. Such structures are evident following treatment with Hg++ or Ag+ salts and are only rarely observed by electron microscopy. If ectodesmata exist without such treatment, and are not artefacts, they would afford natural pathways of entry for applied foliar solutions and plant viruses.


2020 ◽  
Vol 134 (17) ◽  
pp. 2243-2262
Author(s):  
Danlin Liu ◽  
Gavin Richardson ◽  
Fehmi M. Benli ◽  
Catherine Park ◽  
João V. de Souza ◽  
...  

Abstract In the elderly population, pathological inflammation has been associated with ageing-associated diseases. The term ‘inflammageing’, which was used for the first time by Franceschi and co-workers in 2000, is associated with the chronic, low-grade, subclinical inflammatory processes coupled to biological ageing. The source of these inflammatory processes is debated. The senescence-associated secretory phenotype (SASP) has been proposed as the main origin of inflammageing. The SASP is characterised by the release of inflammatory cytokines, elevated activation of the NLRP3 inflammasome, altered regulation of acetylcholine (ACh) nicotinic receptors, and abnormal NAD+ metabolism. Therefore, SASP may be ‘druggable’ by small molecule therapeutics targeting those emerging molecular targets. It has been shown that inflammageing is a hallmark of various cardiovascular diseases, including atherosclerosis, hypertension, and adverse cardiac remodelling. Therefore, the pathomechanism involving SASP activation via the NLRP3 inflammasome; modulation of NLRP3 via α7 nicotinic ACh receptors; and modulation by senolytics targeting other proteins have gained a lot of interest within cardiovascular research and drug development communities. In this review, which offers a unique view from both clinical and preclinical target-based drug discovery perspectives, we have focused on cardiovascular inflammageing and its molecular mechanisms. We have outlined the mechanistic links between inflammageing, SASP, interleukin (IL)-1β, NLRP3 inflammasome, nicotinic ACh receptors, and molecular targets of senolytic drugs in the context of cardiovascular diseases. We have addressed the ‘druggability’ of NLRP3 and nicotinic α7 receptors by small molecules, as these proteins represent novel and exciting targets for therapeutic interventions targeting inflammageing in the cardiovascular system and beyond.


2001 ◽  
Vol 120 (5) ◽  
pp. A153-A153
Author(s):  
S MIYAMOTO ◽  
K KATO ◽  
Y ISHII ◽  
S ASAI ◽  
T NAGAISHI ◽  
...  

2004 ◽  
Vol 171 (4S) ◽  
pp. 94-94
Author(s):  
Yao-Chi Chuang ◽  
Naoki Yoshimura ◽  
Chao-Cheng Huang ◽  
Po-Hui Chiang ◽  
Michael B. Chancellor

Sign in / Sign up

Export Citation Format

Share Document